PRIYA MANDE

Chief Operating Officer, PsiOxus Therapeutics

Priya Mande has over 25 years of experience in the pharmaceutical and biotech sector, 12 of which were at Glaxo Wellcome and GlaxoSmithKline where she most recently supported the R&D Executive.

She has held roles across research, development, finance and business strategy & operations. She was previously at PowderMed responsible for delivery of the vaccine immunotherapeutic portfolio. Priya was the Vaccine Research Project Leader for Influenza at Pfizer before becoming Chief Operating Officer of Hybrid BioSystems in 2009 which then formed PsiOxus Therapeutics in 2010. She joined the Board of Directors in 2016.

Over 10 years she has overseen the growth of PsiOxus in the UK and USA holding responsibility for various parts of the business including project management, clinical development, regulatory, quality, legal, operations, HR and finance – helping to secure over $88M in non-dilutive funding in addition to equity financing.

Priya studied Applied Biochemistry at Brunel University London, has a Diploma in Company Direction from the Institute of Directors and received her MBA with distinction from the London Business School.

 LIVE ONLINE

16 November 2020

BOOK YOUR PLACE NOW

 LIVE ONLINE

17 November 2020

BOOK YOUR PLACE NOW